COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective

被引:10
作者
Cavaillon, Jean-Marc [1 ]
Osuchowski, Marcin F. [2 ]
机构
[1] French Natl Res Agcy ANR, F-75012 Paris, France
[2] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria
来源
JOURNAL OF INTENSIVE MEDICINE | 2021年 / 1卷 / 01期
关键词
Severe acute respiratory syndrome; coronavirus 2 (SARS-CoV-2); Coronavirus; Sepsis; Cytokines; Hydroxychloroquine; Vaccines; Pandemics; INFLAMMATORY RESPONSE; SEPTIC SHOCK; LUNG INJURY; I IFNS; DISEASE; RNA; VECTOR; HYDROXYCHLOROQUINE; METAANALYSIS; ANTIBODIES;
D O I
10.1016/j.jointm.2021.04.003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Humanity has regularly faced the threat of epidemics and pandemics over the course of history. Successful attempts to protect populations were initially made with the development of new vaccines, such as those against plague and cholera, under the leadership of the bacteriologist Waldemar Haffkine. Vaccines have led to a complete eradication of smallpox and bovine plague and a major reduction in other infectious diseases including diphtheria, typhoid fever, poliomyelitis, and Haemophilus influenzae type B meningitis. While a few coronaviruses have been identified that seasonally infect humans causing mild symptoms, the emergence of a new zoonotic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly triggered the ongoing coronavirus disease 2019 (COVID-19) as a global pandemic responsible for widespread mortality. The severe phenotypes of COVID-19 resemble a previous infectious threat that was initially designated as hospital fever and puerperal fever, presently known as sepsis. A SARS-CoV-2 infection has frequently been considered as a form of viral sepsis (owing to common features with bacterial sepsis) but is also associated with an array of specific and unique symptoms. Rapid progress in anti-SARS-CoV-2 vaccine development, in particular, the design of efficient messenger RNA (mRNA) and recombinant adenovirus vaccines, is crucial for curbing the pandemic.
引用
收藏
页码:4 / 13
页数:10
相关论文
共 118 条
[101]   Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus [J].
Tseng, Chien-Te ;
Sbrana, Elena ;
Iwata-Yoshikawa, Naoko ;
Newman, Patrick C. ;
Garron, Tania ;
Atmar, Robert L. ;
Peters, Clarence J. ;
Couch, Robert B. .
PLOS ONE, 2012, 7 (04)
[102]  
Tyndall J., 1870, Scientific Addresses, DOI DOI 10.1038/001339A0
[103]  
vac-lshtm.shinyapps, About us
[104]  
Vallery-Radot Pasteur, 1933, Oeuvres de Pasteur, V6
[105]  
van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]
[106]   Next-generation vaccine platforms for COVID-19 [J].
van Riel, Debby ;
de Wit, Emmie .
NATURE MATERIALS, 2020, 19 (08) :810-812
[107]   Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK [J].
Voysey, Merryn ;
Clemens, Sue Ann Costa ;
Madhi, Shabir A. ;
Weckx, Lily Y. ;
Folegatti, Pedro M. ;
Aley, Parvinder K. ;
Angus, Brian ;
Baillie, Vicky L. ;
Barnabas, Shaun L. ;
Bhorat, Qasim E. ;
Bibi, Sagida ;
Briner, Carmen ;
Cicconi, Paola ;
Collins, Andrea M. ;
Colin-Jones, Rachel ;
Cutland, Clare L. ;
Darton, Thomas C. ;
Dheda, Keertan ;
Duncan, Christopher J. A. ;
Emary, Katherine R. W. ;
Ewer, Katie J. ;
Fairlie, Lee ;
Faust, Saul N. ;
Feng, Shuo ;
Ferreira, Daniela M. ;
Finn, Adam ;
Goodman, Anna L. ;
Green, Catherine M. ;
Green, Christopher A. ;
Heath, Paul T. ;
Hill, Catherine ;
Hill, Helen ;
Hirsch, Ian ;
Hodgson, Susanne H. C. ;
Izu, Alane ;
Jackson, Susan ;
Jenkin, Daniel ;
Joe, Carina C. D. ;
Kerridge, Simon ;
Koen, Anthonet ;
Kwatra, Gaurav ;
Lazarus, Rajeka ;
Lawrie, Alison M. ;
Lelliott, Alice ;
Libri, Vincenzo ;
Lillie, Patrick J. ;
Mallory, Raburn ;
Mendes, Ana V. A. ;
Milan, Eveline P. ;
Minassian, Angela M. .
LANCET, 2021, 397 (10269) :99-111
[108]   Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients [J].
Wang, Nan ;
Zhan, Yan ;
Zhu, Linyu ;
Hou, Zhibing ;
Liu, Feng ;
Song, Pinhong ;
Qiu, Feng ;
Wang, Xiaolin ;
Zou, Xiafei ;
Wan, Deyun ;
Qian, Xiaosong ;
Wang, Shanshan ;
Guo, Yabi ;
Yu, Hao ;
Cui, Miao ;
Tong, Gangling ;
Xu, Yunsheng ;
Zheng, Zhihua ;
Lu, Yingying ;
Hong, Peng .
CELL HOST & MICROBE, 2020, 28 (03) :455-+
[109]   Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins [J].
Wang, Sheng-Fan ;
Tseng, Sung-Pin ;
Yen, Chia-Hung ;
Yang, Jyh-Yuan ;
Tsao, Ching-Han ;
Shen, Chun-Wei ;
Chen, Kuan-Hsuan ;
Liu, Fu-Tong ;
Liu, Wu-Tse ;
Chen, Yi-Ming Arthur ;
Huang, Jason C. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 451 (02) :208-214
[110]   ASSESSMENT OF ABILITY OF MURINE AND HUMAN ANTILIPID-A MONOCLONAL-ANTIBODIES TO BIND AND NEUTRALIZE LIPOPOLYSACCHARIDE [J].
WARREN, HS ;
AMATO, SF ;
FITTING, C ;
BLACK, KM ;
LOISELLE, PM ;
PASTERNACK, MS ;
CAVAILLON, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (01) :89-97